Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
作者: Katsuki DannoTaishi HataKoki TamaiYujiro FujieYoshihito IdeHo Min KimTadashi OhnishiShunji MoritaShinichi YoshiokaToshihiro KudoJunichi NishimuraChu MatsudaHiroki AkamatsuTsunekazu MizushimaRiichiro NezuYuichiro DokiMasaki MoriMulti-Center Clinical Study Group of OsakaColorectal Cancer Treatment Group (MCSGO)
作者单位: 1Osaka General Medical Center
2Osaka University Graduate School of Medicine
3NTT West Osaka Hospital
4Yao Municipal Hospital
5Rinku General Medical Center
6Toyonaka Municipal Hospital
7Nishonomiya Municipal Central Hospital
8Osaka University
9Osaka Police Hospital
刊名: Cancer Chemotherapy and Pharmacology, 2017, Vol.80 (4), pp.777-785
来源数据库: Springer Journal
DOI: 10.1007/s00280-017-3419-1
关键词: Colon cancerXELOXAdjuvantJapaneseSafety
英文摘要: Adjuvant oxaliplatin plus oral capecitabine (XELOX) is recommended for patients with curatively resected colon cancer. However, its safety and tolerability in Asian patients is unclear; therefore, we evaluated the safety and efficacy of adjuvant XELOX in Japanese patients with curatively resected stage III colon cancer (MCSCO-1024) and present the interim safety data.
原始语种摘要: Adjuvant oxaliplatin plus oral capecitabine (XELOX) is recommended for patients with curatively resected colon cancer. However, its safety and tolerability in Asian patients is unclear; therefore, we evaluated the safety and efficacy of adjuvant XELOX in Japanese patients with curatively resected stage III colon cancer (MCSCO-1024) and present the interim safety data.
全文获取路径: Springer  (合作)
分享到:
来源刊物:
影响因子:2.795 (2012)

×
关键词翻译
关键词翻译
  • adjuvant 辅助剂
  • Japanese 日本人日语日本的
  • colon 结肠
  • efficacy 效验
  • cancer 癌症
  • trial 试验
  • stage 
  • safety 安全
  • operated 被操作的
  • interim 临时的